ID   CPT1A_RAT               Reviewed;         773 AA.
AC   P32198; P97780; Q6IMZ4;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   02-OCT-2024, entry version 185.
DE   RecName: Full=Carnitine O-palmitoyltransferase 1, liver isoform;
DE            Short=CPT1-L;
DE            EC=2.3.1.21 {ECO:0000269|PubMed:16908527, ECO:0000269|PubMed:18349115, ECO:0000269|PubMed:21990363};
DE   AltName: Full=Carnitine O-palmitoyltransferase I, liver isoform;
DE            Short=CPT I;
DE            Short=CPTI-L;
DE   AltName: Full=Carnitine palmitoyltransferase 1A;
DE   AltName: Full=Succinyltransferase CPT1A;
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:P50416};
GN   Name=Cpt1a; Synonyms=Cpt-1, Cpt1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=8449948; DOI=10.1016/s0021-9258(18)53392-5;
RA   Esser V., Britton C.H., Weis B.C., Foster D.W., McGarry J.D.;
RT   "Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine
RT   palmitoyltransferase I. Direct evidence that a single polypeptide is
RT   involved in inhibitor interaction and catalytic function.";
RL   J. Biol. Chem. 268:5817-5822(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=9136891; DOI=10.1021/bi962875p;
RA   de Vries Y., Arvidson D.N., Waterham H.R., Cregg J.M., Woldegiorgis G.;
RT   "Functional characterization of mitochondrial carnitine
RT   palmitoyltransferases I and II expressed in the yeast Pichia pastoris.";
RL   Biochemistry 36:5285-5292(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 2-22; 272-283; 585-595 AND 599-606, ACETYLATION AT
RP   ALA-2, NITRATION AT TYR-282 AND TYR-589, PHOSPHORYLATION AT THR-588;
RP   THR-604; SER-741 AND SER-747, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=17478130; DOI=10.1016/j.bbapap.2007.03.012;
RA   Distler A.M., Kerner J., Hoppel C.L.;
RT   "Post-translational modifications of rat liver mitochondrial outer membrane
RT   proteins identified by mass spectrometry.";
RL   Biochim. Biophys. Acta 1774:628-636(2007).
RN   [5]
RP   PROTEIN SEQUENCE OF 4-21; 259-276; 361-379; 529-543 AND 696-717.
RC   TISSUE=Liver;
RX   PubMed=8348957; DOI=10.1016/0014-5793(93)81007-m;
RA   Kolodziej M.P., Zammit V.A.;
RT   "Mature carnitine palmitoyltransferase I retains the N-terminus of the
RT   nascent protein in rat liver.";
RL   FEBS Lett. 327:294-296(1993).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=8449947; DOI=10.1016/s0021-9258(18)53391-3;
RA   Esser V., Kuwajima M., Britton C.H., Krishnan K., Foster D.W.,
RA   McGarry J.D.;
RT   "Inhibitors of mitochondrial carnitine palmitoyltransferase I limit the
RT   action of proteases on the enzyme. Isolation and partial amino acid
RT   analysis of a truncated form of the rat liver isozyme.";
RL   J. Biol. Chem. 268:5810-5816(1993).
RN   [7]
RP   TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Heart;
RX   PubMed=8636126; DOI=10.1074/jbc.271.12.6972;
RA   Esser V., Brown N.F., Cowan A.T., Foster D.W., McGarry J.D.;
RT   "Expression of a cDNA isolated from rat brown adipose tissue and heart
RT   identifies the product as the muscle isoform of carnitine
RT   palmitoyltransferase I (M-CPT I). M-CPT I is the predominant CPT I isoform
RT   expressed in both white (epididymal) and brown adipocytes.";
RL   J. Biol. Chem. 271:6972-6977(1996).
RN   [8]
RP   TOPOLOGY.
RX   PubMed=9169604; DOI=10.1042/bj3230711;
RA   Fraser F., Corstorphine C.G., Zammit V.A.;
RT   "Topology of carnitine palmitoyltransferase I in the mitochondrial outer
RT   membrane.";
RL   Biochem. J. 323:711-718(1997).
RN   [9]
RP   MUTAGENESIS OF ALA-381 AND HIS-473, AND 3D-STRUCTURE MODELING.
RX   PubMed=11553629; DOI=10.1074/jbc.m106920200;
RA   Morillas M., Gomez-Puertas P., Roca R., Serra D., Asins G., Valencia A.,
RA   Hegardt F.G.;
RT   "Structural model of the catalytic core of carnitine palmitoyltransferase I
RT   and carnitine octanoyltransferase (COT): mutation of CPT I histidine 473
RT   and alanine 381 and COT alanine 238 impairs the catalytic activity.";
RL   J. Biol. Chem. 276:45001-45008(2001).
RN   [10]
RP   MUTAGENESIS OF MET-593 AND CYS-608.
RX   PubMed=12499375; DOI=10.1074/jbc.m209999200;
RA   Morillas M., Gomez-Puertas P., Bentebibel A., Selles E., Casals N.,
RA   Valencia A., Hegardt F.G., Asins G., Serra D.;
RT   "Identification of conserved amino acid residues in rat liver carnitine
RT   palmitoyltransferase I critical for malonyl-CoA inhibition. Mutation of
RT   methionine 593 abolishes malonyl-CoA inhibition.";
RL   J. Biol. Chem. 278:9058-9063(2003).
RN   [11]
RP   MUTAGENESIS OF ASP-477; LYS-560; GLU-590; SER-685; THR-686 AND SER-687, AND
RP   3D-STRUCTURE MODELING.
RX   PubMed=14711372; DOI=10.1042/bj20031373;
RA   Morillas M., Lopez-Vinas E., Valencia A., Serra D., Gomez-Puertas P.,
RA   Hegardt F.G., Asins G.;
RT   "Structural model of carnitine palmitoyltransferase I based on the
RT   carnitine acetyltransferase crystal.";
RL   Biochem. J. 379:777-784(2004).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, CATALYTIC ACTIVITY, ACTIVITY REGULATION,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16908527; DOI=10.1074/jbc.m600843200;
RA   Borthwick K., Jackson V.N., Price N.T., Zammit V.A.;
RT   "The mitochondrial intermembrane loop region of rat carnitine
RT   palmitoyltransferase 1A is a major determinant of its malonyl-CoA
RT   sensitivity.";
RL   J. Biol. Chem. 281:32946-32952(2006).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=18192268; DOI=10.1074/jbc.m707965200;
RA   Sierra A.Y., Gratacos E., Carrasco P., Clotet J., Urena J., Serra D.,
RA   Asins G., Hegardt F.G., Casals N.;
RT   "CPT1c is localized in endoplasmic reticulum of neurons and has carnitine
RT   palmitoyltransferase activity.";
RL   J. Biol. Chem. 283:6878-6885(2008).
RN   [14]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=18349115; DOI=10.1152/ajpendo.00497.2007;
RA   Stefanovic-Racic M., Perdomo G., Mantell B.S., Sipula I.J., Brown N.F.,
RA   O'Doherty R.M.;
RT   "A moderate increase in carnitine palmitoyltransferase 1a activity is
RT   sufficient to substantially reduce hepatic triglyceride levels.";
RL   Am. J. Physiol. 294:E969-E977(2008).
RN   [15]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=19136561; DOI=10.1074/jbc.m808487200;
RA   Jenei Z.A., Borthwick K., Zammit V.A., Dixon A.M.;
RT   "Self-association of transmembrane domain 2 (TM2), but not TM1, in
RT   carnitine palmitoyltransferase 1A: role of GXXXG(A) motifs.";
RL   J. Biol. Chem. 284:6988-6997(2009).
RN   [16]
RP   SUBCELLULAR LOCATION, IDENTIFICATION IN A COMPLEX WITH ACSL1 AND VDAC1;
RP   IDENTIFICATION IN COMPLEXES WITH ACSL1; VDAC2 AND VDAC3, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=21622568; DOI=10.1074/jbc.m111.228692;
RA   Lee K., Kerner J., Hoppel C.L.;
RT   "Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an
RT   outer membrane fatty acid transfer complex.";
RL   J. Biol. Chem. 286:25655-25662(2011).
RN   [17]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, DOMAIN, AND MUTAGENESIS
RP   OF GLU-3; ALA-9 AND GLY-18.
RX   PubMed=21990363; DOI=10.1074/jbc.m111.306951;
RA   Rao J.N., Warren G.Z., Estolt-Povedano S., Zammit V.A., Ulmer T.S.;
RT   "An environment-dependent structural switch underlies the regulation of
RT   carnitine palmitoyltransferase 1A.";
RL   J. Biol. Chem. 286:42545-42554(2011).
RN   [18]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=24222496; DOI=10.1007/s12010-013-0619-y;
RA   Hada T., Yamamoto T., Yamamoto A., Ohkura K., Yamazaki N., Takiguchi Y.,
RA   Shinohara Y.;
RT   "Comparison of the catalytic activities of three isozymes of carnitine
RT   palmitoyltransferase 1 expressed in COS7 cells.";
RL   Appl. Biochem. Biotechnol. 172:1486-1496(2014).
CC   -!- FUNCTION: Catalyzes the transfer of the acyl group of long-chain fatty
CC       acid-CoA conjugates onto carnitine, an essential step for the
CC       mitochondrial uptake of long-chain fatty acids and their subsequent
CC       beta-oxidation in the mitochondrion (PubMed:16908527, PubMed:21990363,
CC       PubMed:24222496). Possesses also a lysine succinyltransferase activity
CC       that can regulate enzymatic activity of substrate proteins such as ENO1
CC       and metabolism independent of its classical carnitine O-
CC       palmitoyltransferase activity (By similarity). Plays an important role
CC       in hepatic triglyceride metabolism (PubMed:18349115). Plays also a role
CC       in inducible regulatory T-cell (iTreg) differentiation once activated
CC       by butyryl-CoA that antagonizes malonyl-CoA-mediated CPT1A repression
CC       (By similarity). Sustains the IFN-I response by recruiting ZDHCC4 to
CC       palmitoylate MAVS at the mitochondria leading to MAVS stabilization and
CC       activation (By similarity). {ECO:0000250|UniProtKB:P50416,
CC       ECO:0000269|PubMed:16908527, ECO:0000269|PubMed:18349115,
CC       ECO:0000269|PubMed:21990363, ECO:0000269|PubMed:24222496}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(R)-carnitine + hexadecanoyl-CoA = CoA + O-hexadecanoyl-(R)-
CC         carnitine; Xref=Rhea:RHEA:12661, ChEBI:CHEBI:16347,
CC         ChEBI:CHEBI:17490, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379; EC=2.3.1.21;
CC         Evidence={ECO:0000269|PubMed:16908527, ECO:0000269|PubMed:18349115,
CC         ECO:0000269|PubMed:21990363, ECO:0000269|PubMed:24222496};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12662;
CC         Evidence={ECO:0000305|PubMed:16908527};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl-[protein] + succinyl-CoA = CoA + H(+) + N(6)-succinyl-
CC         L-lysyl-[protein]; Xref=Rhea:RHEA:16261, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:11877, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57292, ChEBI:CHEBI:87830;
CC         Evidence={ECO:0000250|UniProtKB:P50416};
CC   -!- ACTIVITY REGULATION: Inhibited by malonyl-CoA.
CC       {ECO:0000269|PubMed:16908527, ECO:0000269|PubMed:21990363}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=184.2 uM for carnitine {ECO:0000269|PubMed:16908527};
CC         KM=127 mM for carnitine {ECO:0000269|PubMed:18192268};
CC         KM=4.9 mM for palmitoyl-CoA {ECO:0000269|PubMed:18192268};
CC         KM=46.5 uM for palmitoyl-CoA {ECO:0000269|PubMed:16908527};
CC         Vmax=6.6 nmol/min/mg enzyme (towards carnitine)
CC         {ECO:0000269|PubMed:18192268};
CC         Vmax=6.3 nmol/min/mg enzyme (towards palmitoyl-CoA)
CC         {ECO:0000269|PubMed:18192268};
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC   -!- SUBUNIT: Homohexamer and homotrimer (PubMed:19136561). Identified in a
CC       complex that contains at least CPT1A, ACSL1 and VDAC1
CC       (PubMed:21622568). Also identified in complexes with ACSL1 and VDAC2
CC       and VDAC3. Interacts with ZDHHC4 (By similarity).
CC       {ECO:0000250|UniProtKB:P50416, ECO:0000269|PubMed:19136561,
CC       ECO:0000269|PubMed:21622568}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:16908527, ECO:0000269|PubMed:18192268,
CC       ECO:0000269|PubMed:19136561, ECO:0000269|PubMed:21622568}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Liver and kidney. {ECO:0000269|PubMed:8636126}.
CC   -!- DOMAIN: A conformation change in the N-terminal region spanning the
CC       first 42 residues plays an important role in the regulation of enzyme
CC       activity by malonyl-CoA. {ECO:0000269|PubMed:21990363}.
CC   -!- SIMILARITY: Belongs to the carnitine/choline acetyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L07736; AAA40876.1; -; mRNA.
DR   EMBL; U88294; AAB48046.1; -; mRNA.
DR   EMBL; BC072522; AAH72522.1; -; mRNA.
DR   PIR; A46627; A46627.
DR   RefSeq; NP_113747.2; NM_031559.2.
DR   RefSeq; XP_006230757.1; XM_006230695.2.
DR   RefSeq; XP_017444326.1; XM_017588837.1.
DR   AlphaFoldDB; P32198; -.
DR   SMR; P32198; -.
DR   CORUM; P32198; -.
DR   IntAct; P32198; 2.
DR   MINT; P32198; -.
DR   STRING; 10116.ENSRNOP00000019652; -.
DR   BindingDB; P32198; -.
DR   ChEMBL; CHEMBL3858; -.
DR   DrugCentral; P32198; -.
DR   GuidetoPHARMACOLOGY; 3249; -.
DR   SwissLipids; SLP:000000777; -.
DR   GlyGen; P32198; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P32198; -.
DR   PhosphoSitePlus; P32198; -.
DR   SwissPalm; P32198; -.
DR   jPOST; P32198; -.
DR   PaxDb; 10116-ENSRNOP00000019652; -.
DR   Ensembl; ENSRNOT00000019652.4; ENSRNOP00000019652.1; ENSRNOG00000014254.4.
DR   Ensembl; ENSRNOT00055035746; ENSRNOP00055029003; ENSRNOG00055020936.
DR   Ensembl; ENSRNOT00065053227; ENSRNOP00065043724; ENSRNOG00065030877.
DR   GeneID; 25757; -.
DR   KEGG; rno:25757; -.
DR   UCSC; RGD:2396; rat.
DR   AGR; RGD:2396; -.
DR   CTD; 1374; -.
DR   RGD; 2396; Cpt1a.
DR   eggNOG; KOG3716; Eukaryota.
DR   GeneTree; ENSGT01120000271829; -.
DR   HOGENOM; CLU_013513_2_1_1; -.
DR   InParanoid; P32198; -.
DR   OMA; NTEHSWG; -.
DR   OrthoDB; 1429709at2759; -.
DR   PhylomeDB; P32198; -.
DR   TreeFam; TF313836; -.
DR   BioCyc; MetaCyc:MONOMER-14439; -.
DR   BRENDA; 2.3.1.21; 5301.
DR   Reactome; R-RNO-200425; Carnitine metabolism.
DR   Reactome; R-RNO-5362517; Signaling by Retinoic Acid.
DR   SABIO-RK; P32198; -.
DR   UniPathway; UPA00659; -.
DR   PRO; PR:P32198; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000014254; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0004095; F:carnitine O-palmitoyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:1990698; F:palmitoleoyltransferase activity; ISO:RGD.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISO:RGD.
DR   GO; GO:0046222; P:aflatoxin metabolic process; IEP:RGD.
DR   GO; GO:0009437; P:carnitine metabolic process; IDA:UniProtKB.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEP:RGD.
DR   GO; GO:0042755; P:eating behavior; IMP:RGD.
DR   GO; GO:0030855; P:epithelial cell differentiation; ISO:RGD.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IEP:RGD.
DR   GO; GO:0006631; P:fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; IMP:RGD.
DR   GO; GO:0097421; P:liver regeneration; IEP:RGD.
DR   GO; GO:0001676; P:long-chain fatty acid metabolic process; IDA:UniProtKB.
DR   GO; GO:0032000; P:positive regulation of fatty acid beta-oxidation; IMP:RGD.
DR   GO; GO:0045089; P:positive regulation of innate immune response; ISO:RGD.
DR   GO; GO:0031998; P:regulation of fatty acid beta-oxidation; TAS:RGD.
DR   GO; GO:0046320; P:regulation of fatty acid oxidation; IMP:RGD.
DR   GO; GO:0050796; P:regulation of insulin secretion; IMP:RGD.
DR   GO; GO:0010883; P:regulation of lipid storage; IEP:RGD.
DR   GO; GO:0043279; P:response to alkaloid; IEP:RGD.
DR   GO; GO:0045471; P:response to ethanol; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:1904772; P:response to tetrachloromethane; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0006641; P:triglyceride metabolic process; IMP:RGD.
DR   Gene3D; 6.10.250.1760; -; 1.
DR   Gene3D; 3.30.559.10; Chloramphenicol acetyltransferase-like domain; 1.
DR   Gene3D; 3.30.559.70; Choline/Carnitine o-acyltransferase, domain 2; 1.
DR   InterPro; IPR000542; Carn_acyl_trans.
DR   InterPro; IPR023213; CAT-like_dom_sf.
DR   InterPro; IPR039551; Cho/carn_acyl_trans.
DR   InterPro; IPR042231; Cho/carn_acyl_trans_2.
DR   InterPro; IPR032476; CPT_N.
DR   PANTHER; PTHR22589; CARNITINE O-ACYLTRANSFERASE; 1.
DR   PANTHER; PTHR22589:SF74; CARNITINE O-PALMITOYLTRANSFERASE 1, LIVER ISOFORM; 1.
DR   Pfam; PF00755; Carn_acyltransf; 1.
DR   Pfam; PF16484; CPT_N; 1.
DR   SUPFAM; SSF52777; CoA-dependent acyltransferases; 2.
DR   PROSITE; PS00439; ACYLTRANSF_C_1; 1.
DR   PROSITE; PS00440; ACYLTRANSF_C_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Acyltransferase; Direct protein sequencing;
KW   Fatty acid metabolism; Lipid metabolism; Membrane; Mitochondrion;
KW   Mitochondrion outer membrane; Nitration; Phosphoprotein;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix;
KW   Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:17478130"
FT   CHAIN           2..773
FT                   /note="Carnitine O-palmitoyltransferase 1, liver isoform"
FT                   /id="PRO_0000210161"
FT   TOPO_DOM        2..47
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        48..73
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        74..102
FT                   /note="Mitochondrial intermembrane"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        103..122
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        123..773
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        473
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P18886"
FT   BINDING         555..567
FT                   /ligand="CoA"
FT                   /ligand_id="ChEBI:CHEBI:57287"
FT                   /evidence="ECO:0000250|UniProtKB:P18886"
FT   BINDING         589
FT                   /ligand="(R)-carnitine"
FT                   /ligand_id="ChEBI:CHEBI:16347"
FT                   /evidence="ECO:0000250|UniProtKB:P18886"
FT   BINDING         602
FT                   /ligand="(R)-carnitine"
FT                   /ligand_id="ChEBI:CHEBI:16347"
FT                   /evidence="ECO:0000250|UniProtKB:P18886"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:17478130"
FT   MOD_RES         282
FT                   /note="3'-nitrotyrosine"
FT                   /evidence="ECO:0000269|PubMed:17478130"
FT   MOD_RES         588
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:17478130"
FT   MOD_RES         589
FT                   /note="3'-nitrotyrosine"
FT                   /evidence="ECO:0000269|PubMed:17478130"
FT   MOD_RES         604
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:17478130"
FT   MOD_RES         741
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17478130"
FT   MOD_RES         747
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:17478130"
FT   MUTAGEN         3
FT                   /note="E->R: Decreases susceptibility to inhibition by
FT                   malonyl-CoA."
FT                   /evidence="ECO:0000269|PubMed:21990363"
FT   MUTAGEN         9
FT                   /note="A->G: Increases susceptibility to inhibition by
FT                   malonyl-CoA."
FT                   /evidence="ECO:0000269|PubMed:21990363"
FT   MUTAGEN         18
FT                   /note="G->A: Increases susceptibility to inhibition by
FT                   malonyl-CoA."
FT                   /evidence="ECO:0000269|PubMed:21990363"
FT   MUTAGEN         381
FT                   /note="A->D: Reduces activity by 86%. No effect on
FT                   inhibition by malonyl-coenzyme A."
FT                   /evidence="ECO:0000269|PubMed:11553629"
FT   MUTAGEN         473
FT                   /note="H->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:11553629"
FT   MUTAGEN         477
FT                   /note="D->A: Reduces activity by 98%."
FT                   /evidence="ECO:0000269|PubMed:14711372"
FT   MUTAGEN         560
FT                   /note="K->A: Reduces activity by 50%."
FT                   /evidence="ECO:0000269|PubMed:14711372"
FT   MUTAGEN         567
FT                   /note="D->A: Reduces activity by 97%."
FT   MUTAGEN         590
FT                   /note="E->D: Reduces activity by over 60%."
FT                   /evidence="ECO:0000269|PubMed:14711372"
FT   MUTAGEN         593
FT                   /note="M->A,E,S: Almost abolishes inhibition by malonyl-
FT                   coenzyme A."
FT                   /evidence="ECO:0000269|PubMed:12499375"
FT   MUTAGEN         608
FT                   /note="C->A: Slightly lowers inhibition by malonyl-coenzyme
FT                   A."
FT                   /evidence="ECO:0000269|PubMed:12499375"
FT   MUTAGEN         685
FT                   /note="S->A: Reduces activity by 50%."
FT                   /evidence="ECO:0000269|PubMed:14711372"
FT   MUTAGEN         686
FT                   /note="T->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14711372"
FT   MUTAGEN         687
FT                   /note="S->A: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:14711372"
FT   CONFLICT        266
FT                   /note="H -> D (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        374..375
FT                   /note="QP -> NG (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        480
FT                   /note="V -> I (in Ref. 1; AAA40876)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        531
FT                   /note="D -> Y (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        708
FT                   /note="C -> R (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   773 AA;  88125 MW;  8C15594D45430CB8 CRC64;
     MAEAHQAVAF QFTVTPDGID LRLSHEALKQ ICLSGLHSWK KKFIRFKNGI ITGVFPANPS
     SWLIVVVGVI SSMHAKVDPS LGMIAKISRT LDTTGRMSSQ TKNIVSGVLF GTGLWVAVIM
     TMRYSLKVLL SYHGWMFAEH GKMSRSTKIW MAMVKVLSGR KPMLYSFQTS LPRLPVPAVK
     DTVSRYLESV RPLMKEEDFQ RMTALAQDFA VNLGPKLQWY LKLKSWWATN YVSDWWEEYI
     YLRGRGPLMV NSNYYAMEML YITPTHIQAA RAGNTIHAIL LYRRTLDREE LKPIRLLGST
     IPLCSAQWER LFNTSRIPGE ETDTIQHIKD SRHIVVYHRG RYFKVWLYHD GRLLRPRELE
     QQMQQILDDP SEPQPGEAKL AALTAADRVP WAKCRQTYFA RGKNKQSLDA VEKAAFFVTL
     DESEQGYREE DPEASIDSYA KSLLHGRCFD RWFDKSITFV VFKNSKIGIN AEHSWADAPV
     VGHLWEYVMA TDVFQLGYSE DGHCKGDTNP NIPKPTRLQW DIPGECQEVI DASLSSASLL
     ANDVDLHSFP FDSFGKGLIK KCRTSPDAFI QLALQLAHYK DMGKFCLTYE ASMTRLFREG
     RTETVRSCTM ESCNFVQAMM DPKSTAEQRL KLFKIACEKH QHLYRLAMTG AGIDRHLFCL
     YVVSKYLAVD SPFLKEVLSE PWRLSTSQTP QQQVELFDFE KNPDYVSCGG GFGPVADDGY
     GVSYIIVGEN FIHFHISSKF SSPETDSHRF GKHLRQAMMD IITLFGLTIN SKK
//
